Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MENO-CR-40
- Development stage
- Unknown
- Lead developer
- Ergon Pharmaceuticals
- Administration
- Oral
01
Overview
MENO-CR-40 is an Ayurvedic herbal medicinal product developed and marketed by Ergon Pharmaceuticals, a pharmaceutical company based in Bangladesh. Formulated as a capsule, it is primarily indicated for the management of symptoms associated with menopause. As an Ayurvedic preparation, it likely contains a polyherbal blend of traditional ingredients known for their phytoestrogenic or adaptogenic properties, although the specific active constituents and their precise mechanisms of action are not publicly detailed in standard pharmaceutical databases. The product is approved and commercially available in the Bangladeshi market under the Ayurvedic drug license AY 050.
- Brand names
- MENO-CR-40MENO-CR40MENO-CR 40
Beyond the preview
Go deeper on MENO-CR-40.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MENO-CR-40.